An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients
Senate: Accompanied a study order, see S2931
Email me when S 848 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 848. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill adds a new Section 9A to Massachusetts law that requires any covered entity participating in the federal 340B drug‑pricing program to submit an annual report to the Center for Health Information and Analysis. The report must detail drug acquisition costs, payments, prescription volumes, operating expenses such as patient discounts and charity care, and information about contract pharmacies. The aim is to increase transparency and protect vulnerable patients.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 848
3 free questions a day, no accountHearings
- MassHealth Benefits and Provider Reimbursement, Health Equity, and Health Safety NetJoint Committee on Health Care Financing · Jul 15, 2025
History
- Accompanied a study order, see S2931
- Hearing scheduled for 07/15/2025 from 10:00 AM-04:00 PM in Gardner Auditorium
- Referred to the committee on Health Care Financing
- House concurred
Sponsors
- John J. Cronin · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 848 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 848 freeOr ask your AI assistant about S 848 directly:
Add to Claude, ChatGPT or Cursor